Hem#265 Rar ✮

The GR-RAR chimera is a powerful tool for discovering novel RAR ligands and analogues. It improves upon standard assays that exclusively measure gene activation potential, as this system visualizes the receptor's subcellular trafficking. This technique offers significant advantages in studies exploring ligand-induced receptor dynamics. 5. Conclusion

Nuclear receptors, such as the Retinoic Acid Receptor (RAR), are critical in gene regulation but often difficult to monitor in real-time within living cells. This paper explores the development of a GR-RAR chimeric protein, which fuses the nuclear/cytoplasmic translocation properties of the Glucocorticoid Receptor (GR) with the ligand responsiveness of RAR. This chimeric receptor provides a robust, in vivo, real-time translocation assay to detect physiological concentrations of RAR ligands, providing a powerful tool for ligand identification and subcellular trafficking analysis. 1. Introduction Hem#265 rar

The chimeric receptor is designed to remain in the cytoplasm of untreated cells. The GR-RAR chimera is a powerful tool for

Development and Application of a Glucocorticoid/Retinoic Acid Receptor (GR-RAR) Chimera for In Vivo Translocation Assays This chimeric receptor provides a robust, in vivo,

The translocation from cytoplasm to nucleus is observable in living cells, allowing for kinetic studies.

This paper highlights a novel method that combines the ligand-binding domain (LBD) of RAR with the trafficking machinery of the GR, creating a chimeric receptor that moves from the cytoplasm to the nucleus upon ligand binding. 2. Methodology: Design of the GR-RAR Chimera